Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study
- 1 February 1990
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 147 (2) , 239-242
- https://doi.org/10.1176/ajp.147.2.239
Abstract
Ten Alzheimer''s disease patients underwent a trial of oral tetrahydroaminoacridine (THA) and lecithin. After 3 inpatient weeks there was no clear therapeutic effect. Three of six patients able to continue in long-term treatment showed measurable cognitive improvement, but only one displayed clinically obvious improvement.This publication has 0 references indexed in Scilit: